{
    "clinical_study": {
        "@rank": "31685", 
        "arm_group": [
            {
                "arm_group_label": "Lactobacillus GG", 
                "arm_group_type": "Experimental", 
                "description": "Lactobacillus GG given for six weeks two times per day."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo two times per day for six weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Background: Proton pump inhibitors (PPI) are effective for treating gastroesophageal reflux\n      disease (GERD). However, they may be associated with an increased risk of gastrointestinal\n      and respiratory tract infections.\n\n      Aim: To determine if Lactobacillus GG (LGG) is an effective adjunct to PPI for reducing the\n      risk of gastrointestinal and respiratory tract infections in children with GERD.\n\n      Study design: Randomized, double-blind, placebo controlled trial."
        }, 
        "brief_title": "LGG for Prevention of Infectious Complications During PPI Treatment in Children", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Gastroesophageal Reflux Disease", 
            "Gastrointestinal Infections", 
            "Respiratory Tract Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gastroesophageal Reflux", 
                "Respiratory Tract Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with GERD treated with PPI will be randomly assigned to receive LGG in dose of\n      10(9) Colony Forming Units (CFU) twice daily for 6 weeks or a comparable placebo twice daily\n      for 6 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age <5,\n\n          -  clinical symptoms of GERD\n\n          -  treatment with proton pump inhibitors\n\n          -  signed informed consent\n\n        Exclusion Criteria:\n\n          -  treatment with PPI within the last 4 weeks for at least 2 weeks\n\n          -  administration of probiotics within 7 days prior to the study\n\n          -  acute or chronic respiratory tract infections\n\n          -  acute or chronic gastrointestinal tract infections\n\n          -  neurological disorders\n\n          -  immunodeficiency"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782118", 
            "org_study_id": "1/2013"
        }, 
        "intervention": {
            "arm_group_label": [
                "Lactobacillus GG", 
                "Placebo"
            ], 
            "intervention_name": "Lactobacillus GG", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Dicoflor"
        }, 
        "intervention_browse": {
            "mesh_term": "Proton Pump Inhibitors"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 30, 2013", 
        "location": {
            "contact": {
                "email": "katarzynakrenke@gmail.com", 
                "last_name": "Katarzyna Krenlke, MD", 
                "phone": "+48224523204"
            }, 
            "contact_backup": {
                "last_name": "Piotr Dziechciarz, MD", 
                "phone": "+48224523292"
            }, 
            "facility": {
                "address": {
                    "city": "Warsaw", 
                    "country": "Poland", 
                    "zip": "02-091"
                }, 
                "name": "Medical University of Warsaw"
            }, 
            "investigator": [
                {
                    "last_name": "Katarzyna Krenke, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Piotr Dziechciarz, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Hania Szajewska, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Andrea Horvath, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of Lactobacillus GG in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children With Gastroesophageal Reflux Disease Treated With Proton Pump Inhibitors: Randomized Double - Blind Placebo, Controlled Trial.", 
        "other_outcome": [
            {
                "measure": "serum level of 25OHD", 
                "safety_issue": "Yes", 
                "time_frame": "at 6 weeks"
            }, 
            {
                "measure": "serum level of ferritin", 
                "safety_issue": "Yes", 
                "time_frame": "at 6 weeks"
            }, 
            {
                "measure": "Total iron binding capacity", 
                "safety_issue": "Yes", 
                "time_frame": "at 6 weeks"
            }, 
            {
                "measure": "serum level of ferrum", 
                "safety_issue": "Yes", 
                "time_frame": "at 6 weeks"
            }, 
            {
                "measure": "fecal calprotectin", 
                "safety_issue": "No", 
                "time_frame": "at 6 weeks"
            }
        ], 
        "overall_contact": {
            "email": "katarzynakrenke@gmail.com", 
            "last_name": "Katarzyna Krenke, MD", 
            "phone": "+48224523204"
        }, 
        "overall_contact_backup": {
            "email": "piotrdz@hotmail.com", 
            "last_name": "Piotr Dziechciarz, MD", 
            "phone": "+48224523292"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Number of upper and lower respiratory tract infections during intervention plus 3 months after termination of the intervention", 
                "measure": "Respiratory tract infections", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months after termination of intervention"
            }, 
            {
                "description": "Number of gastrointestinal tract infections during during intervention plus 3 months after termination of the intervention", 
                "measure": "Gastrointestinal tract infections", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months after termination of intervention"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782118"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Warsaw", 
            "investigator_full_name": "Hanna Szajewska", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "during intervention plus 3 months after termination of the intervention", 
                "measure": "Number of pneumonias", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months after termination of intervention"
            }, 
            {
                "description": "Number and character of adverse events during intervention plus 3 months after termination of the intervention.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 months after termination of intervention"
            }
        ], 
        "source": "Medical University of Warsaw", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Warsaw", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}